West Pharmaceutical Services (WST) News Today

West Pharmaceutical Services (NYSE:WST - Get Free Report) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $1.52 earnings per share for the quarter, missing analysts' consensus estimates of $1.77 by ($0.25). West Pharmaceutical Services had a net margin of 19.42% and a return on equity of 20.57%. The business had revenue of $702.10 million during the quarter, compared to analysts' expectations of $729.36 million. During the same period in the prior year, the firm posted $2.11 EPS. West Pharmaceutical Services's revenue for the quarter was down 6.9% compared to the same quarter last year.

Vident Advisory LLC boosted its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 467.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,511 shares of the medical instruments suppli

West Pharmaceutical Services, Inc. (NYSE:WST - Get Free Report) saw unusually large options trading on Thursday. Investors acquired 2,133 put options on the stock. This is an increase of 453% compared to the typical daily volume of 386 put options.

West Pharmaceutical Services (NYSE:WST) Sets New 52-Week Low at $265.00

West Pharmaceutical Services (NYSE:WST) updated its FY 2024 earnings guidance. The company provided EPS guidance of 6.350-6.650 for the period, compared to the consensus estimate of 7.740. The company also issued revenue guidance of $2.9 billionillion-$2.9 billionillion, compared to the consensus estimate of $3.0 billionillion.

West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) - Investment analysts at Zacks Research reduced their FY2024 EPS estimates for West Pharmaceutical Services in a research report issued to clients and investors on Tuesday, July 23rd. Zacks Research analyst I. Bandyopadhyay now forecasts

UniSuper Management Pty Ltd grew its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 16.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,647 shares of the medical instruments su

Ontario Teachers Pension Plan Board trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 80.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor

Intech Investment Management LLC trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 22.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,361 shares of the medical inst

Mizuho Markets Americas LLC grew its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 142.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 29,628 shares of the medical instruments supplier's stock

Trillium Asset Management LLC cut its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 55.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,356 shares of the

Entropy Technologies LP lifted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 56.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,281 shares of the medical instruments sup

US Bancorp DE trimmed its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 8.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,918 shares of the medical instruments

Thoroughbred Financial Services LLC decreased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 76.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 640 shares of the medical instruments supplie

Swiss National Bank lowered its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 4.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 221,600 shares of the medical inst

Susquehanna Fundamental Investments LLC bought a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 18,353 shares of the

Mediolanum International Funds Ltd acquired a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm acquired 5,654 shares of the medical instruments supplier's stock, valued at appro

BNP Paribas Financial Markets cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 10.7% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 63,123 shares of the medical instruments supplier's stoc

Tobam boosted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 2,504.9% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,706 shares of the medical instruments supplier's stock after purchasing a

Findlay Park Partners LLP boosted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 30.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 597,106 shares of the med

AMI Asset Management Corp lifted its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 3.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 164,738 shares of the medical instruments s

Cullinan Associates Inc. lessened its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 11.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 30,000 shares of the medical instruments supplier's stock afte

Blue Zone Wealth Advisors LLC bought a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 9,707 shares of the medical instruments supplier's stock, valued at approximatel

Annex Advisory Services LLC reduced its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 33.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,994 shares of the medi

West Pharmaceutical Services (NYSE:WST) Shares Down 6.9%

HighPoint Advisor Group LLC bought a new position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,375 shares of the medical instruments sup

Vanguard Group Inc. raised its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,002,632 shares of the medical instruments

Congress Asset Management Co. MA lowered its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 3.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 328,440 shares of the medical instruments sup

West Pharmaceutical Services, Inc. (NYSE:WST - Get Free Report) SVP Silji Abraham sold 1,800 shares of the company's stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $330.78, for a total value of $595,404.00. Following the completion of the sale, the senior vice president now directly owns 2,860 shares of the company's stock, valued at approximately $946,030.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Gladstone Capital Management LLP decreased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 99.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 891 shares of the medical i

Point72 Hong Kong Ltd purchased a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 34,766 shares of the medical

Cambridge Investment Research Advisors Inc. raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 226.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 7,949 shares of the medical instruments sup

Capital Fund Management S.A. reduced its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 7.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 43,187 shares of the medical instruments supplier'

Sei Investments Co. raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 21.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 338,919 shares of the medical instruments supplier's stock

Epoch Investment Partners Inc. raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 79.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 223,468 shares of the medical instruments su

Pinebridge Investments L.P. grew its position in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 61.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,287 shares of the